Multiple biomarkers measurement to estimate the duration of atrial fibrillation

Background An accurate estimation of the duration of atrial fibrillation is critical for its safe management. Recent studies suggested that copeptin, carbohydrate antigen-125, galectin-3 and growth differentiation factor-15 are increased in atrial fibrillation. We examined the ability of these markers to identify patients presenting with atrial fibrillation of <= 48 versus >48 h duration. Methods Retrospective analysis of a prospective study that included patients with atrial fibrillation of known duration. Results A total of 98 patients were analysed, 47 with atrial fibrillation <= 48 h and 51 with >48 h. In patients presenting with atrial fibrillation of <= 48 versus >48 h duration, the mean carbohydrate antigen-125 concentration was 16.9 +/- 12.5 versus 30.9 +/- 36.3 U/mL (P = 0.01), and growth differentiation factor-15 concentration was 1320 +/- 889 versus 2608 +/- 2163 pg/mL (P < 0.001). Copeptin concentration was not independently associated with atrial fibrillation duration. The galectin-3 concentration did not differ between groups. Area under the ROC curve to identify patients with atrial fibrillation <= 48 h was 0.869 for carbohydrate antigen-125, 0.853 for growth differentiation factor-15. Conclusion The plasma concentrations of carbohydrate antigen-125, growth differentiation factor-15 and copeptin, but not galectin-3, are higher in patients presenting with atrial fibrillation of >48 h duration than in those with atrial fibrillation <= 48 h. The ability to discriminate recent atrial fibrillation offered by carbohydrate antigen-125 and growth differentiation factor-15 seems high.

Automated summary

This study examined the ability of several markers to identify patients with different durations of atrial fibrillation. The results showed that carbohydrate antigen-125 and growth differentiation factor-15 had high accuracy in discriminating patients with shorter atrial fibrillation duration.